99 related articles for article (PubMed ID: 27631803)
1. Detection of Protein SUMOylation In Situ by Proximity Ligation Assays.
Sahin U; Jollivet F; Berthier C; de Thé H; Lallemand-Breitenbach V
Methods Mol Biol; 2016; 1475():139-50. PubMed ID: 27631803
[TBL] [Abstract][Full Text] [Related]
2. Small Ubiquitin-like Modifier Alters IFN Response.
Maarifi G; Maroui MA; Dutrieux J; Dianoux L; Nisole S; Chelbi-Alix MK
J Immunol; 2015 Sep; 195(5):2312-24. PubMed ID: 26223657
[TBL] [Abstract][Full Text] [Related]
3. Detection of Protein-Protein Interactions and Posttranslational Modifications Using the Proximity Ligation Assay: Application to the Study of the SUMO Pathway.
Ristic M; Brockly F; Piechaczyk M; Bossis G
Methods Mol Biol; 2016; 1449():279-90. PubMed ID: 27613043
[TBL] [Abstract][Full Text] [Related]
4. Real-Time Surface Plasmon Resonance (SPR) for the Analysis of Interactions Between SUMO Traps and Mono- or PolySUMO Moieties.
Xolalpa W; Rodriguez MS; England P
Methods Mol Biol; 2016; 1475():99-107. PubMed ID: 27631800
[TBL] [Abstract][Full Text] [Related]
5. SIM-dependent enhancement of substrate-specific SUMOylation by a ubiquitin ligase in vitro.
Parker JL; Ulrich HD
Biochem J; 2014 Feb; 457(3):435-40. PubMed ID: 24224485
[TBL] [Abstract][Full Text] [Related]
6. In Situ SUMOylation and DeSUMOylation Assays: Fluorescent Methods to Visualize SUMOylation and DeSUMOylation in Permeabilized Cells.
Yuasa E; Saitoh H
Methods Mol Biol; 2016; 1475():151-9. PubMed ID: 27631804
[TBL] [Abstract][Full Text] [Related]
7. Assay methods for small ubiquitin-like modifier (SUMO)-SUMO-interacting motif (SIM) interactions in vivo and in vitro using a split-luciferase complementation system.
Hirohama M; Voet AR; Ozawa T; Saitoh H; Nakao Y; Zhang KY; Ito A; Yoshida M
Anal Biochem; 2014 Mar; 448():92-4. PubMed ID: 24333278
[TBL] [Abstract][Full Text] [Related]
8. A Fluorescent In Vitro Assay to Investigate Paralog-Specific SUMO Conjugation.
Eisenhardt N; Chaugule VK; Pichler A
Methods Mol Biol; 2016; 1475():67-78. PubMed ID: 27631798
[TBL] [Abstract][Full Text] [Related]
9. Arsenic degrades PML or PML-RARalpha through a SUMO-triggered RNF4/ubiquitin-mediated pathway.
Lallemand-Breitenbach V; Jeanne M; Benhenda S; Nasr R; Lei M; Peres L; Zhou J; Zhu J; Raught B; de Thé H
Nat Cell Biol; 2008 May; 10(5):547-55. PubMed ID: 18408733
[TBL] [Abstract][Full Text] [Related]
10. Dynamics of component exchange at PML nuclear bodies.
Weidtkamp-Peters S; Lenser T; Negorev D; Gerstner N; Hofmann TG; Schwanitz G; Hoischen C; Maul G; Dittrich P; Hemmerich P
J Cell Sci; 2008 Aug; 121(Pt 16):2731-43. PubMed ID: 18664490
[TBL] [Abstract][Full Text] [Related]
11. Identification and Characterization of SUMO-SIM Interactions.
Husnjak K; Keiten-Schmitz J; Müller S
Methods Mol Biol; 2016; 1475():79-98. PubMed ID: 27631799
[TBL] [Abstract][Full Text] [Related]
12. SUMO: of branched proteins and nuclear bodies.
Seeler JS; Dejean A
Oncogene; 2001 Oct; 20(49):7243-9. PubMed ID: 11704852
[TBL] [Abstract][Full Text] [Related]
13. Human stanniocalcin-1 interacts with nuclear and cytoplasmic proteins and acts as a SUMO E3 ligase.
dos Santos MT; Trindade DM; Gonçalves Kde A; Bressan GC; Anastassopoulos F; Yunes JA; Kobarg J
Mol Biosyst; 2011 Jan; 7(1):180-93. PubMed ID: 21042649
[TBL] [Abstract][Full Text] [Related]
14. Production and Purification of Recombinant SUMOylated Proteins Using Engineered Bacteria.
Brockly F; Piechaczyk M; Bossis G
Methods Mol Biol; 2016; 1475():55-65. PubMed ID: 27631797
[TBL] [Abstract][Full Text] [Related]
15. Solubility shift and SUMOylaltion of promyelocytic leukemia (PML) protein in response to arsenic(III) and fate of the SUMOylated PML.
Hirano S; Tadano M; Kobayashi Y; Udagawa O; Kato A
Toxicol Appl Pharmacol; 2015 Sep; 287(3):191-201. PubMed ID: 26049103
[TBL] [Abstract][Full Text] [Related]
16. Visualizing and quantifying protein polySUMOylation at the single-molecule level.
Yang Y; Zhang CY
Anal Chem; 2014 Jan; 86(2):967-72. PubMed ID: 24383460
[TBL] [Abstract][Full Text] [Related]
17. Cell cycle-dependent SUMO-1 conjugation to nuclear mitotic apparatus protein (NuMA).
Seo JS; Kim HN; Kim SJ; Bang J; Kim EA; Sung KS; Yoon HJ; Yoo HY; Choi CY
Biochem Biophys Res Commun; 2014 Jan; 443(1):259-65. PubMed ID: 24309115
[TBL] [Abstract][Full Text] [Related]
18. SUMO1 negatively regulates the transcriptional activity of EVI1 and significantly increases its co-localization with EVI1 after treatment with arsenic trioxide.
Singh S; Pradhan AK; Chakraborty S
Biochim Biophys Acta; 2013 Oct; 1833(10):2357-68. PubMed ID: 23770046
[TBL] [Abstract][Full Text] [Related]
19. SUMO E3 ligases are expressed in the retina and regulate SUMOylation of the metabotropic glutamate receptor 8b.
Dütting E; Schröder-Kress N; Sticht H; Enz R
Biochem J; 2011 Apr; 435(2):365-71. PubMed ID: 21288202
[TBL] [Abstract][Full Text] [Related]
20. MAP Kinase: SUMO pathway interactions.
Yang SH; Sharrocks AD
Methods Mol Biol; 2010; 661():343-67. PubMed ID: 20811994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
